PHARMACEUTICAL RAW MATERIALS AND EXCIPIENTS OPTIONS

“The existing condition has uncovered some structural weaknesses from the EU’s medicines provide chain along with a substantial dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides explained. She encouraged that supply chain issues be dealt with within an EU pharmaceutical strategy predicted to be l